Dr. Cullis and co-workers have been responsible for fundamental advances in the development of nanomedicines employing lipid nanoparticle (LNP) technology for cancer therapies, gene therapies and vaccines.
Ashley was inspired to study this growing field of dynamic DNA nanotechnology as one of the skills it requires is creativity for both DNA design and problem solving.
